Rh İzoimmünizasyonu

Costumbrado J, Mansour T, Ghassemzadeh S. Rh Incompatibility. [Updated 2024 May 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459353/

Hendrickson JE, Delaney M. Hemolytic disease of the fetus and newborn: modern practice and future investigations. Transfus Med Rev. 2016;30(4):159–64. https://doi.org/10.1016/j.tmrv.2016.05.008

Visser GHA, Thommesen T, Di Renzo GC. FIGO/ICM guidelines for preventing Rhesus disease: A call to action. Int J Gynaecol Obstet. 2021;152(2):144–7. https://doi.org/10.1002/ijgo.13459

Bergström H, Nilsson LA, Nilsson L. Demonstration of Rh antigens in a 38-day-old fetus. Am J Obstet Gynecol. 1967;99(1):130–3. https://doi.org/10.1016/s0002-9378(16)34502-1

Medearis AL, Hensleigh PA, Parks DR. Detection of fetal erythrocytes in maternal blood post partum with the fluorescence-activated cell sorter. Am J Obstet Gynecol. 1984;148(3):290–5. https://doi.org/10.1016/s0002-9378(84)80070-8

Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang. 1986;51(2):117–21. https://doi.org/10.1111/j.1423-0410.1986.tb00226.x

Zipursky A, Paul VK. The global burden of Rh disease. Arch Dis Child Fetal Neonatal Ed. 2011;96(2):F84–5. https://doi.org/10.1136/adc.2009.181172

Pollack W, Ascari WQ, Kochesky RJ. Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion. 1971;11(6):333–9. https://doi.org/10.1111/j.1537-2995.1971.tb04424.x

Boctor FN, Ali NM, Mohandas K. Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion. 2003;43(2):173–6. https://doi.org/10.1046/j.1537-2995.2003.00289.x

Kumpel BM. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Transfusion. 2006;46(9):1652–6. https://doi.org/10.1111/j.1537-2995.2006.00924_1.x

Hadley AG. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn. Transpl Immunol. 2002;10(2-3):191–8. https://doi.org/10.1016/s0966-3274(02)00065-5

Koenig JM, Christensen RD. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr. 1989;114(4 Pt 1):625–31. https://doi.org/10.1016/s0022-3476(89)80709-7

van den Akker ES, de Haan TR, Lopriore E. Severe fetal thrombocytopenia in Rhesus D alloimmunized pregnancies. Am J Obstet Gynecol. 2008;199(4):387.e1–4. https://doi.org/10.1016/j.ajog.2008.07.001

Sağlık Bakanlığı. Doğum öncesi bakım rehberi. 2019. Available from: https://hsgm.saglik.gov.tr/depo/Yayinlarimiz/Rehberler/dogum_oncesi_bakim_08-01-2019_1.pdf

Bhutani VK, Zipursky A, Blencowe H. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(Suppl 1):86–100. https://doi.org/10.1038/pr.2013.208

Crowther C, Middleton P. Anti-D administration after childbirth for preventing rhesus alloimmunisation. Cochrane Database Syst Rev. 2000;1997:CD000021.

McBain RD, Crowther CA, Middleton P. Anti-D administration in pregnancy for preventing rhesus alloimmunisation. Cochrane Database Syst Rev. 2015;2015:CD000020.

Contreras M. The prevention of Rh haemolytic disease of the fetus and newborn—general background. Br J Obstet Gynaecol. 1998;105(Suppl 18):7–10.